¯q°ª´Nµê°²ºô¯¸´£¿ô«È¤á : ¯q°ªÃҨ馳­­¤½¥q (¥H¤U²ºÙ¡u¯q°ª¡v) ªñ¤éµo²{°°«_¥»¦æºô¯¸ / ³n¥ó¡A¬ÛÃöºô¯¸©Î¥H´Û¶B¥Ø¼Ð¡A´£¿ô¤½²³ª`·N¡C µê°²ºô§}¬O: https://ygzq-china.com ¯q°ª´£¿ô¤½²³¤H¤h¡A¥H¤W ºô¯¸ / ³n¥ó »P¥»¦æµLÃö¡A¥»¥q¤§©x¤èºô§}¬° http://www.yicko.com¡C «È¤áÀ³¦bÂsÄý¾¹¦a§}Äæ¤W¿é¤J¯q°ªªº©x¤èºô§}¡C°²­Y§A¾á¤ß¤w¸g©ÜÅS¤F­Ó¤H¸ê®Æ¡A½ÐºÉ§Ö¦Vĵ¤è³ø®×¡C «È¤á¦p¦³¬d¸ß¡A½Ð­P¹q ¯q°ª«È¤áªA°È¼ö½u (852) 2946 1320¡C ¯q°ª²{¤w±À¥Xºô¤WªÑ²¼¶R½æ¡A¦p¦³¥ô¦ó¬d¸ß¡A½Ð­P¹q (852)2544 1055 ©Î¶Ç¯u¦Ü (852)2544 4361 ©Î¹q¶l¦Ü info@yicko.com¡C
/
©µ¿ð³ø»ù °]¸g·s»D ¤½¥q³zµø
ºÛ½ü§Ö³t·j´M¾¹
ªÑ¥«¸ê°T
³Ì¬¡ÅDªÑ²¼
¥»¦a«ü¼Æ
¦¨¥÷ªÑ
¸g¬ö·j¼v
ªÑ²¼ªfªÅ
¤½¥q¦^ÁÊ
¤½¥q¦WºÙ§ó§ï
³Ð·~ªO
ùÚ«üªí²{
ªÑ²¼³ø»ù
§Y®É·s»D
°]¸g·s»D
Áp©Ò·s»D
Àô²y¥«³õ
¥@¬É¦U¦a«ü¼Æ
¬ü°ê®§²v
¥~¶×
¤½¥q¸ê®Æ®w
¤½¥q³zµø
·sªÑ³t»¼
»È¦æ®§²v
¦P·~©î®§
¸gÀÙ±´¯Á
®ø¶Oª«»ù«ü¼Æ
¥»¦a¥Í²£Á`­È
¹s°â·~¼Æ¾Ú
®È¹C·~¼Æ¾Ú
¥¢·~²v¼Æ¾Ú
¶T©ö¼Æ¾Ú
°]°È¤u¨ã
´ÁÅv­pºâªk
¶U´Ú­pºâ¾÷
­»´ä»È¦æ¦W³æ
¤W¥«¤½¥q¦W³æ

ªø¦¿¥Í©R¬ì§Þ¶°¹Î¦³­­¤½¥q
(
ªÑ¥÷¥N¸¹¡G8222)

©ÛªÑ¸ê®Æ

µo°âªÑ¥÷¼Æ¥Ø¡G

1,307,000,000ªÑ

°t°âªÑ¥÷¼Æ¥Ø¡G

1,176,300,000ªÑ

¤½¶}µo°â¼Æ¥Ø¡G

130,700,000ªÑ

¨CªÑµo°â»ù¡G

2.0´ä¤¸

²¼­±­È¡G

0.10´ä¤¸

¶°¸êª÷ÃB¡G

¤Ö©ó2,640,000,000´ä¤¸

¹w´Á¥«­È¡G

¤Ö©ó12,814,000,000 ´ä¤¸

¥D®u¡G

§õ¿A¹d¥ý¥Í

«OÂˤH¡G

©Òùªù¬ü¨¹­»´ä¦³­­¤½¥q

±¾µP¤W¥«¤é´Á¡G

2002¦~7¤ë16¤é

¥D­nªÑªF

  • ªø¦¿¹ê·~(¶°¹Î)¦³­­¤½¥q ¡V 44.02%Åv¯q
  • >
  • §õ¹Å¸Û¥ý¥Í ¡V 29.34%Åv¯q

ªþÄݤ½¥q

  • PT Far East Agritech (¾Ö¦³60%Åv¯q)¡G¦b¦L¥§±À¼s¡B¤À¾P¤Î¾P°âªÎ®Æ
  • Biocycle Resources Ltd (¥þ¸ê¾Ö¦³)¡G±q¨Æ¶R½æ¥Íª«¬ì§Þ²£«~
  • ªø¦¿¥Í©R¬ì§Þ¦³­­¤½¥q (¥þ¸ê¾Ö¦³)¡G±q¨Æ¥Íª«¬ì§Þ²£«~¤§À³¥Î¬ã¨s¡B¥Í²£¡B²£«~¶}µo©M°Ó«~¤Æ¡C
  • ªø¦¿¥Í¤Æ¬ã¨s©Ò(¥þ¸ê¾Ö¦³)¡G±q¨Æ¬ã¨s¤Î¶}µo
  • Ultra Biotech Limited (¥þ¸ê¾Ö¦³)¡G±q¨Æ«ù¦³±M§QÅv¤Î°Ó¼Ð¡A¨Ã±N¸Óµ¥±M§QÅv¤Î°Ó¼Ð¤§³\¥i±Â§Ç¸Ó¶°¹ÎºX¤U¤§¤½¥q
  • CK Life Sciences Int¡¦l Inc (¥þ¸ê¾Ö¦³)¡G±q¨Æ±N¥Íª«¬ì§Þ²£«~°Ó«~¤Æ

·~°È·§Äý

¸Ó¶°¹Î±q¨Æ¥Íª«¬ì§Þ²£«~¤§¬ã¨s»P¶}µo¡B°Ó«~¤Æ¡B¥«°È±À¼s¤Î¾P°â¡C¾ÌµÛ¦b²£«~¶}µo¤Î°Ó«~¤Æ¤è­±¤§Àu¶Õ¡A¸Ó¶°¹Î¦®¦b¦¨¬°¤@®a¥@¬É¯Å¤§¥þ²y©Ê¥Íª«¬ì§Þ¤½¥q¡A´N­¢¤Á¤Î´¶¹M¤§Àô¹Ò¦Ã¬V¤Î¤HÃþ°·±d°ÝÃD´£¨Ñ¸Ñ¨M¤è®×¡C

¸Ó¶°¹Î¤w»{©w¤F5­Ó¨ãÀu½è°Ó·~¼ç¤O¤§¥Ø¼Ð¥«³õ¡A¨Ã¶}µo¤@¨t¦C²£«~¡A¥Hº¡¨¬¸Óµ¥¥«³õ¤§»Ý¨D¡C¸³¨Æ­Ì¬Û«H¡A²{®É©ó¸Óµ¥¥«³õ¥i¨Ñ±Ä¥Î¤§¦h¶µ¸Ñ¨M¤è®×¡Aªí²{¤Î/©Î¼ç¦b¤§­P®`©Ê°Æ§@¥Î¨Ã¤£²z·Q¡C¸Ó¶°¹Î5­Ó­«ÂIµo®i¤§²£«~¤Î²£«~¬ã¨s»P¶}µo¥«³õ¬°¥ÍºA¹A·~¡BÀô¹Òªv²z¡BÂåÃÄ¡B«O°·­¹«~¤ÎÅ@½§¥Î«~¡C

¸Ó¶°¹Î¤§¬ã¨s¤Î°Ó«~¤Æ¤u§@¤À§O¥Ñ¨â®aªþÄݤ½¥q­t³d¡Aªø¦¿¥Í¤Æ¬ì§Þ¬ã¨s©Ò¦³­­¤½¥q­t³dµo©ú·s²£«~¡ACK Life Sciences Int¡¦l.,Inc.«h­t³d±N¦¹µ¥·s²£«~°Ó«~¤Æ¡C¸³¨Æ­Ì¬Û«H¡A¸Ó¶°¹Î¥i±NºÂ¿ï·L¥Íª«¡B¿E¬¡¥\¯à¤Î¦bÀô¹Ò¤¤¹¥¤Æ¤§³B²z¹Lµ{¤Î¤èªk¡AÀ³¥Î©ó¬ã¨s»P¶}µo¼sªx¤§¥Íª«¬ì§Þ²£«~¡C

¸Ó¶°¹ÎºX¤U¤§¬ã¨s»P¶}µo¤Î°Ó«~¤Æ¶¤¥î¥]¬A¤À¤l¥Íª«¾Ç¡B¥Í¤Æ¾Ç¡Bµ²ºc¥Íª«¾Ç¡B¥\¯à³J¥ÕÅé¾Ç¡B¤Æ¾Ç¤ÎÃIJz¾Çµ¥¤§±M®a¡C¸Ó¶°¹Î¥ç»P°ê»Ú©Ê¤½¥q¡BÂå°|¡B¬F©²¾÷ºc¡BÀô«O²Õ´¤Î¾Ç³N¾÷ºc¦X§@¡AÂǦ¹´£°ª¸Ó¶°¹Î¦b¬ã¨s»P¶}µo¤Î°Ó«~¤Æ¤§¯à¤O¡C

Ävª§Àu¶Õ

¸Ó¶°¹Î¤w¹ê²{¥H¤U¨½µ{¸O¥]¬A (¥u¨ÒÁ|³¡¥÷)¡G

  • ¦b­»´ä¤j®H¤u·~°Ï¦¨¥ß³]³Æ§¹µ½¤§¬ã¨s©Ò¡F
  • ²Õ¦¨¬ì¾Ç®a¶¤¥î¡A­t³d±N²£«~°Ó«~¤Æ¤ÎºÉ¶q´£¤É²£«~¤§¥«³õÄvª§¤O¡A¨Ã©Û¸u¦h¦ì·~°Èµo®i¤H­û¥H¨Ñ¸Ó¶°¹Î¤§·~°Èµ¦²¤µo®i¤Î¹B§@¡F
  • ©ó³Ì«á¹ê»Ú¥i¦æ¤é´Á¡A108¶µ²£«~¤¤, ¦³27¶µ±M§QÅv¥Ó½Ð¤w»¼¥æ¬ü°ê±M§Q¤Î°Ó¼Ðµù¥U³B¡A¨ä¥L81¶µ±M§QÅv¥Ó½Ð¥¿¶i¦æ¯óÀÀ¤u§@¡G
  • ¦b¶W¹L10­Ó°ê®a¹ï¹O50ºØ¹A§@ª«¶i¦æ¤§¥ÍºAªÎ²{³õ¸ÕÅç¤w§¹¦¨¡F
  • ¸Ó¶°¹Î­º§åÂåÃIJ£«~¦b¤¤°ê¶i¦æ¤§ªì¨B¤HÅé´ú¸Õ¤w¶}©l¡F

­·ÀI¦]¯À

  • ¸Ó¶°¹Î¸gÀç¾ú¥v©|µu¡F
  • ¸Ó¶°¹Î´¿¿ý±o¸gÀçÁ«·l¡A¦Ó¸ÓÁ«·l¹w´Á±N·|«ùÄò¡F
  • ¸Ó¶°¹Î¦Û¦¨¥ß¥H¨Ó¨Ì¿à¤jªÑªF¤§°]°È¤ä«ù¡F
  • ¸Ó¶°¹Î¥i¯à­±¹ï¥D­n¹µ­û¤§­·ÀI¡A¥]¬A²Ä¤TªÌ¯ÁÀv¡F
  • ¸Ó¶°¹Î¤§²£«~¬Û¹ï¹ñ·s¡A¨ä°Ó·~®Ä¥Î¥¼¸gÅçÃÒ¡A¦]¦¹¥¼¯à½T©w¬O§_¤@©w¦¨¥\¡F
  • ¸Ó¶°¹Î²£«~¤§´ú¸Õ¥i¯à¬O¤@­Óº©ªø¤Î©ù¶Q¤§¹Lµ{¡A¬G¦¹¦s¦b©µ»~©Î¥¢±Ñ¤§­·ÀI¡F

ºî¦X°]°È¸ê®Æ

³æ¦ì¡G(´ä¹ô/¤d¤¸)

ºI¦Ü12¤ë31¤é¤î¦~«×

ºI¦Ü3¤ë31¤é

¡@

2000

2001

2002 (3­Ó¤ë)

Àç·~ÃB

-

148

134

°£µ|«e(Á«·l)/·¸§Q

(137,467)

(57,896)

(22,146)

ªÑªFÀ³¦û(Á«·l)·¸§Q

(137,491)

(57,934)

(22,146)

Á`¸ê²£

186,326

245,705

263,316

Á`­t¶Å

323,816

441,13

480,887

Á`ªÑ¥»

(137,491)

(195,425)

(217,571)

¥¼¨Ó­p¹º

¸Ó¶°¹Î¥H¦¨¬°¥@¬É¯Å¥Íª«¬ì§Þ¶°¹Î¬°¥Ø¼Ð¡A³z¹L¥Íª«¬ì§Þ¬ã¨s¦¨ªG¡A§ïµ½¤HÃþ°·±d¤Î¼W±jÀô¹Ò¤§¥i«ùÄòµo®i¯à¤O¡A±q¦Ó´£¤É¥Í¬¡½è¯À¡C¬°¹ê½î¦¹¤@¥Ø¼Ð¡A¸Ó¶°¹Î¾U·N¦¨¬°¥þ²y©Ê¤Î·~°È½d³òÂл\¼sªx¤§¥Íª«¬ì§Þ²£«~¨ÑÀ³°Ó¡C¸Ó¶°¹Î¤§¥D¦®¬O¾ÌÂÇ¥»¨­¤§¬ã¨s¤Î°Ó«~¤Æ±M¤~¡A§â´¤²{¦³¥ÍºA¹A·~¡BÀô¹Òªv²z¡BÂåÃÄ¡B«O°·­¹«~¤ÎÅ@½§¥Î«~¤§¾÷·|¡A¨Ã¶}µo¥X°Ó·~¥«³õ¥i¥H¼sªx±Ä¥Î¤§²£«~¡C

¸Ó¶°¹Î§@¬°¤@®a¥Íª«¬ì§Þ¤½¥q¡A¨ä­º­n­«ÂI¦b¶}µo·sÀ³¥Î¤è®×¡B¬ã¨s´£°ª²£«~¤§ªí²{¤Î¨ä¦b¥«³õÄvª§¤O¡C¸Ó¶°¹Î­p¹º«O¯dª¾ÃѲ£Åv¤§©Ò¦³Åv¡A°È¨D§â¨äª¾ÃѲ£Åv»ù­È´£¤É¦Ü³Ì°ª¡C¦]¦¹¡A¸Ó¶°¹ÎÀÀª½±µºÞ²z¡B¨ÃÄY±KºÊ±±²£«~ (§Y¿E¬¡·L¥Íª«) ¸g¹L³B²z¤§§÷®Æªì´Á¤§¥Í²£µ{§Ç¤Î³]¬I¡CµM¦Ó¡A¸Ó¶°¹Î·|±Ä¯ÇÆF¬¡¥Í²£¡B¤À¾P ¤Î±À¼s»s¦¨«~¤§µ¦²¤¡A¦b¥i¦æ±¡ªp¤U·|¸u¥Î¿W¥ß²Ä¤TªÌ§¹¦¨¤u§@¡C

¸Ó¶°¹Î¤§µ¦²¤¬O¥Î¦XÀç©Î¯S³\¸gÀçÅv¤è¦¡¡A»P¦UÃþ²£«~¤Î¤£¦P¦a°Ï¾Õªø¦³Ãö½dÃ¥¹B§@¤§¸ó°ê¤½¥q©Î¦b·í¦a¥«³õí¦û­«­n®u¦ì¤§¤½¥q¦X§@¡A¦®¦bÂX¤j¥«°È¯à¤O¡C¦¹Á|±N¥O¸Ó¶°¹Î¥R¤À§Q¥Î¨ä¸ê·½¡A¨Ã¥[§Ö²£°Ó«~¤Æ¤§¨B¥ï¡C­Õ¦b¬Y¨Ç±¡ªp¤U³]¥ß¦XÀç¹Ù¦ñÃö«Y¨Ã¤£¥i¦æ¡A¶°¹Î·|¨Ï¥Î¨ä¥»¨­¤§Àç·~¶¤¥îª½±µ¾P°â­Y¤z²£«~¡C

¸Ó¶°¹Î¤§³Ì²×¥Ø¼Ð¬O«Ø¥ß¤@­Ó§¹µ½¤§¯S³\¸gÀç¨î«×¥H±À¼s¨ä²£«~¡A¦b¦¹¨î«×¤º«O¯dª¾ÃѲ£Åv¤§©Ò¦³Åv¡A¤Î¨ä²£«~¤§ÃöÁä­ì®Æ¡A¦Ó·~°Èñà¦ñ©Î¯S³\¸gÀç°Ó«h­t³d¤j³¡¤À°Ó·~¬¡°Ê¡C

¶°¸ê¥Î³~

­Õ¤£­p¤J¦æ¨Ï¶WÃB°tªÑÅv©Ò±o´Ú¶µ¡A«ö°t°â»ù2.0´ä¤¸¡A¸Ó¶°¹Î¥Ñ°t°â©Ò±o´Ú¶µ²bÃB¦ô­p¦X¦@¬ù¬°24»õ8400¸U´ä¤¸(¸g¦©°£¥]¾P¤Î°t°â¦þª÷¤Î¦ô­p¤ä¥X«á)¡A±N«ö¤U¦C¦w±Æ¡F

´Ú¶µ¥Î³~

¦û¶°¸ê²bÃB¤ñ²v

¥Î©ó¬ãµo»P¶}µo

34.2%

¥Î©óÂX¥R»s³y¤Î¬ã¨s»P¶}µo³]¬I

10.1%

¥Î©ó¶}©Ý¥«³õ¤Î«Ø¥ß«~µP¡A¤Î«Ø¥ß¥«°È±À¼s¤Î¾P°âºôµ¸

14.1%

¥Î©óª½±µ¤Î¶¡±µ§ë¸ê©ó¥Íª«¬ì§Þ¬ÛÃö·~°È

20.1%

¥Î§@¤é«á¤@¯ëÀç¹B¸êª÷

21.5%

Copyright © 2002 Yicko Securities Limited All rights reserved.   Powered by Infocast Limited   [ §K³dÁn©ú ]